Please login to the form below

Not currently logged in
Email:
Password:

biologic

This page shows the latest biologic news and features for those working in and with pharma, biotech and healthcare.

AZ says target of $45bn sales by 2023 still achievable

AZ says target of $45bn sales by 2023 still achievable

patient prescriptions in the US and Germany and topping all biologics for asthma on that measure in Japan.

Latest news

More from news
Approximately 20 fully matching, plus 587 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2018

    non‐ biologic product post‐ patent loss, highlighting the benefits of biologics in the long term and the complexities of developing and manufacturing them. ... $307m. Samsung Bioepis/. Merck &Co. Lusduna Nexvue follow‐ on biologic. Termination.

  • Nudge-nudge, think-think Nudge-nudge, think-think

    The power of achieving the triad of capability, opportunity and peer endorsement is evidenced by a recent study into how to avoid retrograde outcomes when switching patients from biologics to biosimilars.

  • Making Europe a leader in bioscience: boosting trust and opening minds Making Europe a leader in bioscience: boosting trust and opening minds

    New disruptive innovation is changing the way we create value in healthcare: big data, artificial intelligence, the growing role of patients, the discovery of new materials and biologics, gene, cell and

  • AstraZeneca: building a new ‘open innovation’ pharma company AstraZeneca: building a new ‘open innovation’ pharma company

    and biologics housed under the same roof. ... Co-locating scientists who work on chemistry and small molecule drug development with scientists who work on biologics, large molecules and protein based therapeutics, in lab-based environments for the first

  • Cancer immunotherapy: What's on the horizon? Cancer immunotherapy: What's on the horizon?

    targeting drugs from the likes of Crescendo Biologics and Pfizer, and Celldex’CD27-targeting antibody varlilumab which is in phase II testing for various solid tumour types. ... Meanwhile, AbbVie and Johnson &Johnson have both struck deals this year

More from intelligence
Approximately 2 fully matching, plus 71 partially matching documents found.

Latest appointments

More from appointments
Approximately 7 fully matching, plus 45 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 9 fully matching, plus 58 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics